General Anesthesia — MCQs

General Anesthesia Indian Medical PG Practice Questions and MCQs

Question 121: Which of the following is a feature of Verill's sign?

A. Partial ptosis
B. Blurring of vision
C. Slurring of speech
D. All of the above (Correct Answer)

Explanation: **Explanation:** **Verrill’s Sign** is a clinical endpoint used to gauge the depth of conscious sedation, most commonly during the administration of intravenous benzodiazepines (like Midazolam or Diazepam). It represents the transition point between deep sedation and the onset of general anesthesia. 1. **Why "All of the above" is correct:** Verrill’s sign is characterized by a cluster of symptoms resulting from the depressant effect of sedatives on the central nervous system and cranial nerve function: * **Partial Ptosis (The Hallmark):** This is the most classic sign, defined as the drooping of the upper eyelid until it covers approximately half of the pupil. It indicates significant muscle relaxation and CNS depression. * **Blurring of Vision:** As the extraocular muscles relax and accommodation is affected, the patient experiences diplopia or blurred vision. * **Slurring of Speech:** This occurs due to the relaxation of the muscles of articulation and decreased cortical control over speech. 2. **Analysis of Options:** While **Partial Ptosis** is the "classic" definition often tested, clinically, the sign is a syndrome. Since blurring of vision and slurred speech occur simultaneously as the patient reaches this level of sedation, "All of the above" is the most accurate description of the clinical presentation. 3. **Clinical Pearls for NEET-PG:** * **Clinical Significance:** It is used to determine the "optimal sedation level" for dental or minor surgical procedures. Beyond this point, the patient may lose their protective airway reflexes. * **The "Guedel’s" Connection:** While Guedel’s stages describe General Anesthesia, Verrill’s sign is specific to **IV Sedation**. * **High-Yield Tip:** If a question asks for the *earliest* or *most characteristic* component of Verrill's sign, choose **Partial Ptosis**. If "All of the above" is an option, it usually refers to the complete clinical picture.

Question 122: Uses of Neuroleptanalgesia include which of the following?

A. As premedication
B. As a supplement to thiopentone
C. To provide sedation during operations under regional analgesia
D. All of the above (Correct Answer)

Explanation: **Explanation:** **Neuroleptanalgesia (NLA)** is a state of profound sedation and analgesia produced by the combination of a potent neuroleptic (typically **Droperidol**) and a potent opioid analgesic (typically **Fentanyl**). The most common commercially available preparation is **Innovar**, which contains these drugs in a fixed ratio of 50:1 (Droperidol 2.5 mg/mL and Fentanyl 0.05 mg/mL). **Why "All of the above" is correct:** The unique properties of NLA—characterized by "mineralization" (quiescence), intense analgesia, and decreased motor activity—make it versatile: * **As Premedication (Option A):** It provides excellent preoperative sedation and blunts the sympathetic response to intubation. * **Supplement to Thiopentone (Option B):** It can be used to deepen anesthesia or reduce the dose requirements of induction agents like Thiopentone, ensuring smoother maintenance. * **Sedation during Regional Analgesia (Option C):** It is ideal for keeping a patient calm, pain-free, and cooperative during procedures performed under spinal or epidural blocks. **Clinical Pearls for NEET-PG:** 1. **Neuroleptanesthesia:** If NLA is combined with an inhalation agent (like Nitrous Oxide), it is termed *Neuroleptanesthesia*. 2. **The "Fixed Ratio" Problem:** While Innovar is convenient, the long half-life of Droperidol (up to 24 hours) compared to the short half-life of Fentanyl can lead to postoperative respiratory depression or prolonged sedation. 3. **Contraindications:** Avoid in patients with **Parkinson’s disease** (due to Droperidol’s dopamine-blocking effects) and those with a history of **long QT syndrome**. 4. **Patient State:** Patients under NLA appear "detached" from their surroundings but can often follow simple commands, a state sometimes referred to as "twilight sleep."

Question 123: Which of the following anesthetic agents is nephrotoxic?

A. Halothane
B. Methoxyflurane (Correct Answer)
C. Ether
D. Cyclopropane

Explanation: **Explanation:** **Methoxyflurane** is the correct answer because it is the most potent and lipid-soluble volatile anesthetic, but it undergoes extensive hepatic metabolism (approx. 50–70%). This metabolism releases high levels of **inorganic fluoride ions (F⁻)**. These ions interfere with the action of Antidiuretic Hormone (ADH) in the distal convoluted tubules and collecting ducts, leading to **Vasopressin-resistant high-output renal failure**. Due to this dose-related nephrotoxicity, its use as a general anesthetic has been largely abandoned. **Analysis of Incorrect Options:** * **Halothane:** Primarily known for **hepatotoxicity** ("Halothane Hepatitis") rather than nephrotoxicity. It is metabolized to trifluoroacetic acid, which can trigger an immune-mediated liver injury. * **Ether:** Historically significant but not nephrotoxic. Its main drawbacks include high flammability, slow induction, and significant post-operative nausea and vomiting (PONV). * **Cyclopropane:** An explosive gas that is not nephrotoxic. Its primary clinical concern was "Cyclopropane shock" (hypotension upon discontinuation) and sensitization of the myocardium to catecholamines, leading to arrhythmias. **High-Yield Clinical Pearls for NEET-PG:** * **Fluoride-induced Nephrotoxicity:** Methoxyflurane (highest risk) > Enflurane > Sevoflurane. * **Sevoflurane & Compound A:** Sevoflurane can react with soda lime (CO₂ absorbers) to produce **Compound A**, which is nephrotoxic in rats, though clinical significance in humans is minimal if fresh gas flows are >1-2 L/min. * **Desflurane:** Has the lowest metabolism (0.02%) and is the least likely to cause organ toxicity. * **Penthrox:** Methoxyflurane is still used in very low doses via a "Green Whistle" inhaler for emergency analgesia, where it does not reach nephrotoxic thresholds.

Question 124: Which general anesthetic selectively inhibits excitatory NMDA receptors?

A. Thiopentone
B. Halothane
C. Desflurane
D. Ketamine (Correct Answer)

Explanation: **Explanation:** **Ketamine** is a unique phencyclidine derivative that acts as a non-competitive antagonist at the **N-methyl-D-aspartate (NMDA) receptors**. By selectively inhibiting these excitatory glutamate receptors, it disrupts the communication between the limbic system and the thalamocortical system. This results in **"Dissociative Anesthesia,"** where the patient appears conscious (eyes open, intact swallow reflex) but is unable to process sensory input or feel pain. **Analysis of Incorrect Options:** * **Thiopentone (Option A):** A barbiturate that primarily acts by enhancing **GABA-A receptors** (inhibitory), increasing the duration of chloride channel opening. * **Halothane & Desflurane (Options B & C):** These volatile inhalational anesthetics primarily act on **GABA-A and glycine receptors**, while also inhibiting excitatory nicotinic acetylcholine receptors. While they have some minor effects on various channels, they are not selective NMDA inhibitors. **High-Yield Clinical Pearls for NEET-PG:** 1. **Sympathetic Stimulation:** Unlike most anesthetics, Ketamine increases HR, BP, and Cardiac Output (due to indirect sympathomimetic action). 2. **Bronchodilation:** It is the induction agent of choice for **Asthmatic patients**. 3. **Analgesia:** It provides profound systemic analgesia even at sub-anesthetic doses. 4. **Side Effects:** Associated with **Emergence Delirium** (minimized by Benzodiazepines) and increased Intracranial/Intraocular pressure. 5. **Preserved Reflexes:** It maintains airway reflexes and respiratory drive, making it useful in short procedures and emergency "field" anesthesia.

Question 125: All are true about sodium thiopental except?

A. It is an ultra-short acting barbiturate.
B. It is cerebroprotective.
C. It is the induction agent of choice in neurosurgery. (Correct Answer)
D. It is contraindicated in acute intermittent porphyria.

Explanation: **Explanation:** The correct answer is **C** because, while Sodium Thiopental was historically the gold standard, **Propofol** has replaced it as the induction agent of choice in neurosurgery. Propofol is preferred because it allows for rapid recovery and a predictable "neurological wake-up test," which is crucial for post-operative assessment. **Analysis of Options:** * **Option A (True):** Thiopental is an **ultra-short-acting barbiturate**. Its rapid onset (30–45 seconds) and short duration of action (5–10 minutes) are due to **redistribution** from the brain to less vascular tissues like muscle and fat, rather than rapid metabolism. * **Option B (True):** It is highly **cerebroprotective**. It decreases the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) and causes cerebral vasoconstriction, which leads to a decrease in Cerebral Blood Flow (CBF) and **Intracranial Pressure (ICP)**. * **Option D (True):** Barbiturates are absolute contraindications in **Acute Intermittent Porphyria**. They induce the enzyme *ALA synthetase*, which accelerates the production of porphyrins, potentially precipitating a life-threatening crisis. **High-Yield Clinical Pearls for NEET-PG:** * **pH & Stability:** Thiopental is highly alkaline (pH 10.5). Accidental **intra-arterial injection** causes severe vasospasm and gangrene. Treatment includes Heparin, Papaverine, and Lidocaine/Procaine. * **Garlic/Onion Taste:** Patients often report a metallic or garlic taste during induction. * **Context-Sensitive Half-life:** Thiopental has a long elimination half-life; repeated doses lead to "hangover" effects due to saturation of fat stores. * **Gold Standard for Status Epilepticus:** It remains a potent anticonvulsant.

Question 126: A 32-year-old chronic alcoholic patient with a known case of chronic liver disease is scheduled for an emergency laparoscopic appendectomy. Which of the following inhalational anesthetic agents should be used for induction?

A. Methoxyflurane
B. Sevoflurane
C. Desflurane (Correct Answer)
D. Isoflurane

Explanation: **Explanation:** The primary concern in a patient with chronic liver disease (CLD) undergoing anesthesia is the potential for drug-induced hepatotoxicity and the preservation of hepatic blood flow. **Why Desflurane is the Correct Answer:** Desflurane is the preferred inhalational agent in this scenario because it undergoes the **least amount of hepatic metabolism** (only **0.02%**). Since it is minimally metabolized by the liver, it produces the lowest concentration of trifluoroacetylated protein adducts, making the risk of "halothane-like" hepatitis virtually non-existent. Furthermore, Desflurane preserves hepatic arterial blood flow better than older agents, which is crucial in a patient with already compromised liver function. **Analysis of Incorrect Options:** * **A. Methoxyflurane:** It has the highest rate of metabolism (approx. 50%) and is notoriously nephrotoxic due to the release of inorganic fluoride ions. It is contraindicated in almost all modern surgical settings. * **B. Sevoflurane:** While commonly used, it undergoes significantly more metabolism (approx. 2–5%) than Desflurane. It also carries a theoretical risk of nephrotoxicity due to Compound A formation. * **D. Isoflurane:** Isoflurane is also relatively safe for liver patients (metabolism ~0.2%), but Desflurane remains the superior choice due to its even lower metabolic rate and faster recovery profile. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism Gradient:** Methoxyflurane (50%) > Halothane (20%) > Sevoflurane (2%) > Isoflurane (0.2%) > Desflurane (0.02%). * **Halothane Hepatitis:** Caused by the metabolite **trifluoroacetic acid**. Desflurane produces the least, while Halothane produces the most. * **Agent of Choice for CLD:** Desflurane or Isoflurane (Desflurane is preferred for its minimal metabolism). * **Emergency Laparoscopy:** Rapid emergence provided by Desflurane is beneficial for airway protection in emergency cases.

Question 127: Which skeletal muscles are relaxed first by tubocurarine?

A. Respiratory muscles
B. Head and neck muscles
C. Finger muscles (Correct Answer)
D. Limb muscles

Explanation: **Explanation:** The sequence of muscle paralysis following the administration of non-depolarizing neuromuscular blockers (like d-Tubocurarine) follows a specific clinical pattern based on muscle size, blood flow, and metabolic activity. **1. Why Finger Muscles are correct:** Neuromuscular blockade typically affects **small, rapidly moving muscles** first. These include the muscles of the fingers, toes, eyes (extraocular), and ears. These muscles have a high density of receptors but are more sensitive to the competitive inhibition of acetylcholine by tubocurarine. Therefore, the paralysis starts peripherally at the extremities (fingers) and moves centrally. **2. Analysis of Incorrect Options:** * **Head and Neck muscles (Option B):** These are affected shortly after the small muscles of the fingers and eyes but are not the very first to relax. * **Limb muscles (Option C):** Larger muscles of the trunk and limbs are affected after the small peripheral muscles but before the respiratory muscles. * **Respiratory muscles (Option A):** The **diaphragm** is the most resistant muscle to non-depolarizing blockers and is the **last to be paralyzed**. This is a protective physiological mechanism; conversely, the diaphragm is the first to recover during the reversal of blockade. **3. NEET-PG High-Yield Pearls:** * **Order of Paralysis:** Small distal muscles (Fingers/Eyes) → Muscles of the Face/Neck → Limbs → Trunk → Intercostal muscles → Diaphragm. * **Order of Recovery:** Exactly the reverse (Diaphragm recovers first; Fingers recover last). * **Clinical Significance:** During induction, we monitor the "Adductor Pollicis" (thumb) using a peripheral nerve stimulator to gauge the depth of block, as it reflects the status of peripheral muscle relaxation. * **Rule of Thumb:** "Small muscles first, Diaphragm last."

Question 128: Which of the following statements about nitrous oxide is true?

A. It has little effect on respiration. (Correct Answer)
B. It is a good muscle relaxant.
C. It is lighter than air.
D. It causes diffusion hypoxia.

Explanation: **Explanation:** **Nitrous Oxide ($N_2O$)** is a colorless, odorless inorganic gas widely used in anesthesia. **1. Why Option A is correct:** Nitrous oxide is unique among inhalational agents because it has **minimal effect on respiration**. Unlike volatile agents (like Sevoflurane or Isoflurane), which significantly depress the ventilatory response to CO2 and decrease tidal volume, $N_2O$ maintains relatively stable minute ventilation. While it may slightly increase respiratory rate and decrease tidal volume, the overall effect on spontaneous respiration is negligible at clinical concentrations. **2. Why the other options are incorrect:** * **Option B:** $N_2O$ provides excellent analgesia but has **no muscle relaxant properties**. In fact, at high concentrations, it may cause increased muscle tone or rigidity. * **Option C:** $N_2O$ is **1.5 times heavier than air**. Its molecular weight is 44, whereas the average molecular weight of air is approximately 29. * **Option D:** While $N_2O$ is associated with diffusion hypoxia, the question asks for a "true statement" regarding its pharmacological properties. In modern practice, **diffusion hypoxia is prevented** by administering 100% oxygen for 5–10 minutes after discontinuing $N_2O$. Therefore, saying it "causes" it as an inherent property in a clinical setting is less accurate than its respiratory stability. *(Note: In some exam contexts, D is considered a side effect, but A is the definitive physiological characteristic).* **High-Yield NEET-PG Pearls:** * **Blood-Gas Partition Coefficient:** 0.47 (Low solubility = Fast induction/recovery). * **MAC Value:** 104% (Least potent inhalational agent; cannot be used as a sole anesthetic). * **Second Gas Effect:** $N_2O$ accelerates the uptake of a companion volatile anesthetic. * **Contraindications:** Avoid in pneumothorax, bowel obstruction, and middle ear surgeries (it expands closed air-filled spaces). * **Toxicity:** Prolonged exposure inhibits **Vitamin B12 synthesis** (methionine synthase), leading to megaloblastic anemia or myeloneuropathy.

Question 129: The Bispectral index is used for what purpose?

A. Determining the potency of general anesthesia
B. Determining the speed of induction of general anesthesia
C. Monitoring the depth of general anesthesia (Correct Answer)
D. None of the above

Explanation: **Explanation:** The **Bispectral Index (BIS)** is a processed EEG parameter used to monitor the **depth of anesthesia**. It converts complex raw EEG data into a single dimensionless number ranging from 0 to 100, providing a real-time objective assessment of the patient’s level of consciousness. * **Why Option C is correct:** The primary clinical goal of BIS monitoring is to ensure adequate hypnosis and prevent **intraoperative awareness**. By quantifying the hypnotic effect of anesthetic drugs on the brain, it allows the anesthesiologist to titrate drug delivery precisely. * **Why Option A is incorrect:** The potency of an inhalational anesthetic is determined by its **MAC (Minimum Alveolar Concentration)**, which is a pharmacokinetic/dynamic property of the drug itself, not a monitoring tool. * **Why Option B is incorrect:** The speed of induction is determined by the drug’s solubility (Blood:Gas partition coefficient) and the concentration administered, not by the BIS monitor. **High-Yield Clinical Pearls for NEET-PG:** * **BIS Scale Interpretation:** * **100:** Awake/Alert. * **40–60:** Recommended range for **General Anesthesia** (low probability of consciousness). * **0:** Isoelectric EEG (Brain death/Deep coma). * **Benefits:** Reduces anesthetic drug consumption, shortens recovery time, and decreases the incidence of post-operative nausea and vomiting (PONV). * **Limitation:** BIS values can be falsely elevated by certain drugs like **Ketamine** (which increases high-frequency EEG activity) or by neuromuscular blockers (due to reduced electromyographic interference).

Question 130: What is the specific antagonist for benzodiazepines?

A. Flumazenil (Correct Answer)
B. Alprazolam
C. Diisopropylphenol
D. Cremophor EL

Explanation: **Explanation:** **Correct Option: A. Flumazenil** Flumazenil is a specific, competitive antagonist at the benzodiazepine (BZD) binding site on the **GABA-A receptor** complex. It effectively reverses the sedative, anxiolytic, and muscle-relaxant effects of benzodiazepines. It is the drug of choice for managing BZD overdose and for reversing conscious sedation induced during clinical procedures. **Analysis of Incorrect Options:** * **B. Alprazolam:** This is a short-acting benzodiazepine itself, used primarily for anxiety and panic disorders. It acts as an agonist, not an antagonist. * **C. Diisopropylphenol:** This is the chemical name for **Propofol**, a common intravenous induction agent. It acts primarily by enhancing GABAergic neurotransmission but is unrelated to BZD antagonism. * **D. Cremophor EL:** This is a polyoxyethylated castor oil used as a **solubilizing agent (vehicle)** for drugs with poor water solubility, such as the original formulation of Propofol and certain chemotherapy drugs. It is associated with histamine release and anaphylactoid reactions. **High-Yield Clinical Pearls for NEET-PG:** * **Half-life:** Flumazenil has a shorter half-life (~1 hour) than most benzodiazepines. This can lead to **"re-sedation,"** necessitating repeated doses or a continuous infusion. * **Seizure Risk:** Use with caution in patients on long-term BZDs or those with a history of epilepsy, as rapid reversal can precipitate **acute withdrawal seizures**. * **Specific Reversals to Remember:** * Opioids → Naloxone * Heparin → Protamine Sulfate * Organophosphates → Atropine/Pralidoxime * Rocuronium/Vecuronium → Sugammadex

Practice by Chapter

History of Anesthesia

Practice Questions

Preoperative Evaluation

Practice Questions

Pharmacology of Inhalational Anesthetics

Practice Questions

Pharmacology of Intravenous Anesthetics

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Airway Management

Practice Questions

Endotracheal Intubation

Practice Questions

Difficult Airway Algorithms

Practice Questions

Intraoperative Monitoring

Practice Questions

Depth of Anesthesia Monitoring

Practice Questions

Emergence from Anesthesia

Practice Questions

Postoperative Care

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free